The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Peca Labs sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Peca Labs is a medical equipment company that designs and manufactures cardiovascular implantable devices. The company offers cardiovascular grafts and heart valves. The company uses a polymer platform and a novel design approach to develop and manufacture its products. Its vascular graft product portfolio includes Exgraft, Exgraft II and Okapi. The company also offers polymeric pulmonary valve conduit Masavalve and polymeric transcatheter aortic valve Stealth. Peca Labs. Peca Labs is headquartered in Pittsburgh, Pennsylvania, the US.
The key metrics of Peca Labs related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Peca Labs is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Peca Labs.
For a detailed understanding of the performance of Peca Labs, buy the report here.